United Pharm (033270) - Total Liabilities

Latest as of March 2026: ₩103.96 Billion KRW ≈ $70.45 Million USD

Based on the latest financial reports, United Pharm (033270) has total liabilities worth ₩103.96 Billion KRW (≈ $70.45 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

United Pharm - Total Liabilities Trend (2011–2025)

This chart illustrates how United Pharm's total liabilities have evolved over time, based on quarterly financial data. See how liquid is United Pharm's working capital to evaluate short-term liquidity relative to the company's equity base.

United Pharm Competitors by Total Liabilities

The table below lists competitors of United Pharm ranked by their total liabilities.

Company	Country	Total Liabilities
DCW Limited NSE:DCW	India	Rs10.15 Billion
Duos Technologies Group Inc NASDAQ:DUOT	USA	$20.29 Million
Gozde Girisim Sermayesi Yatirim Ortakligi AS IS:GOZDE	Turkey	TL904.99 Million
Proficient Auto Logistics, Inc. Common Stock NASDAQ:PAL	USA	$163.00 Million
Profile Systems & Software SA AT:PROF	Greece	€47.57 Million
Barings Participation Investors (the Trust) NYSE:MPV	USA	$44.52 Million
Helix Acquisition Corp. II Class A Ordinary Shares NASDAQ:HLXB	USA	$8.15 Million
Gia Lai Electricity JSC VN:GEG	Vietnam	₫8.69 Trillion

Liability Composition Analysis (2011–2025)

This chart breaks down United Pharm's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see United Pharm stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.36	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.23	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.18	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how United Pharm's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for United Pharm (2011–2025)

The table below shows the annual total liabilities of United Pharm from 2011 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩64.86 Billion ≈ $43.96 Million	-4.22%
2024-12-31	₩67.72 Billion ≈ $45.89 Million	-24.90%
2023-12-31	₩90.18 Billion ≈ $61.11 Million	+12.68%
2022-12-31	₩80.03 Billion ≈ $54.24 Million	+0.90%
2021-12-31	₩79.32 Billion ≈ $53.76 Million	+3.63%
2020-12-31	₩76.54 Billion ≈ $51.87 Million	+0.52%
2019-12-31	₩76.14 Billion ≈ $51.60 Million	+3.64%
2018-12-31	₩73.47 Billion ≈ $49.79 Million	+14.59%
2017-12-31	₩64.11 Billion ≈ $43.45 Million	+12.81%
2016-12-31	₩56.83 Billion ≈ $38.52 Million	+2.84%
2014-12-31	₩55.27 Billion ≈ $37.45 Million	+6.07%
2013-12-31	₩52.10 Billion ≈ $35.31 Million	-3.69%
2012-12-31	₩54.10 Billion ≈ $36.66 Million	-5.16%
2011-12-31	₩57.04 Billion ≈ $38.66 Million	--

About United Pharm

KO:033270 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$182.53 Million

₩269.34 Billion KRW

Market Cap Rank

#17006 Global

#669 in Korea

Share Price

₩18650.00

Change (1 day)

+0.81%

52-Week Range

₩17500.00 - ₩22350.00

All Time High

₩95918.11